Calvert, Oncoceutics partner for cancer R&D; Pharma Medica adding 320 jobs;

> CRO Calvert Research and biotech Oncoceutics have partnered to take the latter's experimental cancer drug to the IND stage. News

> The changing world of drug development has created some confusion between sponsors and CROs as to just who's supposed to do what. Feature

> Pharma Medica Research is spending $30.8 million to open a Missouri lab that will employ about 320 people. Article

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.